Dr Jemima Beissbarth

Senior Research Officer, Child and Maternal Health Division

Qualifications:

PhD, Charles Darwin University, 2022 Graduate Certificate in Clinical Epidemiology, University of Newcastle, 2014 Bachelor of Science/Bachelor of Teaching, 2004

Approved level of HDR supervision at Charles Darwin University:

Associate Supervisor

Location:

Darwin – Royal Darwin Hospital Campus

Biography

Dr Beissbarth recently completed her PhD in otitis media (middle ear disease) microbiology. Her research focus is the bacteria involved in sustaining chronic disease, the associated antimicrobial resistance, and vaccine impact on these bacteria, including pneumococcal vaccines.

Dr Jemima Beissbarth
Email
Research Themes
  • Otitis media /   Chronic suppurative otitis media (ears)
  • Pneumococcal diseases and immunisations
     
  1. Beissbarth, J., Smith-Vaughan, H. C., Cheng, A. C., Morris, P. S., & Leach, A. J. (2022). BIGDATA: A Protocol to Create and Extend a 25-Year Clinical Trial and Observational Data Asset to Address Key Knowledge Gaps in Otitis Media and Hearing Loss in Australian Aboriginal and Non-Aboriginal Children. Front Pediatr, 10, 804373. doi:10.3389/fped.2022.804373
  2. Beissbarth, J., Wilson, N., Arrowsmith, B., Binks, M. J., Oguoma, V. M., Lawrence, K., . . . Leach, A. J. (2021). Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial. Vaccine, 39(16), 2264-2273. doi:10.1016/j.vaccine.2021.03.032
  3. Binks, M. J., Beissbarth, J., Oguoma, V. M., Pizzutto, S. J., Leach, A. J., Smith-Vaughan, H. C., . . . Chang, A. B. (2020). Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study. Lancet Child Adolesc Health, 4(6), 425-434. doi:10.1016/S2352-4642(20)30090-0
  4. Bowman-Derrick, S., Harris, T. M., Beissbarth, J., Kleinecke, M., Lawrence, K., Wozniak, T. M., . . . Smith-Vaughan, H. (2023). Can non-typeable Haemophilus influenzae carriage surveillance data infer antimicrobial resistance associated with otitis media? Pediatr Investig, 7(1), 13-22. doi:10.1002/ped4.12364
  5. Leach, A. J., Mulholland, E. K., Santosham, M., Torzillo, P. J., McIntyre, P., Smith-Vaughan, H. C., . . . Morris, P. S. (2021). Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial. Vaccine X, 7, 100086. doi:10.1016/j.jvacx.2021.100086
  6. Leach, A. J., Mulholland, E. K., Santosham, M., Torzillo, P. J., McIntyre, P., Smith-Vaughan, H. C., . . . Morris, P. S. (2021). Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial. BMC Pediatr, 21(1), 117. doi:10.1186/s12887-021-02552-z
  7. Leach, A. J., Wilson, N., Arrowsmith, B., Beissbarth, J., Mulholland, E. K., Santosham, M., . . . Morris, P. S. (2022). Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. Lancet Infect Dis. doi:10.1016/s1473-3099(22)00272-9
  8. Marsh, R. L., Aho, C., Beissbarth, J., Bialasiewicz, S., Binks, M., Cervin, A., . . . Smith-Vaughan, H. C. (2020). Panel 4: Recent advances in understanding the natural history of the otitis media microbiome and its response to environmental pressures. Int J Pediatr Otorhinolaryngol, 130 Suppl 1(Suppl 1), 109836. doi:10.1016/j.ijporl.2019.109836
  9. Smith-Vaughan, H., Temple, B., Trang Dai, V. T., Hoan, P. T., Loc Thuy, H. N., Phan, T. V., . . . Mulholland, K. (2023). Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trial. Lancet Reg Health West Pac, 32, 100651. doi:10.1016/j.lanwpc.2022.100651
  10. Temple, B., Nation, M. L., Dai, V. T. T., Beissbarth, J., Bright, K., Dunne, E. M., . . . Mulholland, K. (2021). Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in Vietnam. Vaccine, 39(16), 2303-2310. doi:10.1016/j.vaccine.2021.02.04